Posts tagged poultry
Avivagen in JV for OxC-beta in China

Avivagen (TSX-V:VIV) has signed an agreement with Shaanxi Jintai Mining, a widely diversified Chinese company, to form a joint venture company to commercialize OxC-beta Livestock in China.

The JV will initially target OxC-beta for use in poultry and swine, with an option for use in cattle and goats (bovines and caprines).

Read More
Avivagen in OxC-beta pact with UNAHCO

Avivagen (TSX-V:VIV) has agreed to supply OxC-beta Livestock to UNAHCO for sales and distribution in the Republic of the Philippines.

OxC-beta has been shown to be effective and economic in replacing the antibiotics commonly added to livestock feeds. Comprised of fully-oxidized beta-carotene, OxC-beta is a non-antibiotic means of maintaining optimal health and growth in livestock animals such as swine and poultry.

Read More
Avivagen plans JV to sell OxC-beta in China

Avivagen (TSX-V:VIV) plans to collaborate with the Jintai group of companies for a joint venture to commercialize OxC-beta Livestock in China.

The companies plan to create a Sino-Canadian joint venture company based in Xi’an, Shaanxi province, to register and commercialize OxC-beta Livestock, initially for use in poultry and swine.

Read More
Avivagen starts OxC-beta Livestock trial with poultry

Avivagen (TSX-V:VIV) has started a new broiler poultry trial with the institute of agro-food research and technology of Catalonia, Spain.

The trial will test the efficacy of OxC-beta Livestock to enhance performance and welfare of healthy broiler chickens raised under typical production conditions. Subject to minor enhancements to the protocol, the trial is a replicate of the study conducted by the Spanish institute for Avivagen in 2015.

Read More